Stocks and Finance

BioDelivery Sciences

BioDelivery Sciences 4/17/2012

23:34 : BioDelivery Sciences gets $15 million after patent extension - The Raleigh drug company had the patent extended for its experimental treatment for chronic pain. The extension resulted in a $15 million milestone payment from partner Endo Pharmaceuticals.Click to Continue »
Source : newsobserver-com

BioDelivery Sciences 3/28/2012

06:29 : Exclusive Video Q&A With President and CEO of BioDelivery Sciences - LOS ANGELES, CA--(Marketwire - Mar 28, 2012) - Mark A. Sirgo is the President and CEO of BioDelivery Sciences International, Inc. (NASDAQ: BDSI). After spending more than 20 years in the pharmaceutical industry with companies ...
Source : marketwire-com

BioDelivery Sciences 2/22/2012

12:03 : BioDelivery Sciences scores victory in patent battle - BioDelivery Sciences today announced more good news in its ongoing patent battle involving Onsolis, its oral pain patch for cancer patients.Click to Continue »
Source : newsobserver-com

BioDelivery Sciences 2/16/2012

13:45 : BioDelivery Sciences shares soar - Shares of BioDelivery Sciences International jumped as much as 28 percent this morning after the Raleigh company announced that it was in line for a $15 million milestone payment.Click to Continue »
Source : newsobserver-com

BioDelivery Sciences 1/6/2012

11:42 : BioDelivery Sciences lands $180 million drug development deal - BioDelivery Sciences International announced today that it has signed a license and development agreement with Endo Pharmaceuticals for its experimental treatment for chronic pain.
Source : newsobserver-com

BioDelivery Sciences 1/2/2012

13:05 : BioDelivery Sciences hails FDA program - BioDelivery Sciences International anticipates that new federal regulations for narcotic painkillers used by cancer patients will level the playing field for its drug Onsolis.
Source : newsobserver-com

BioDelivery Sciences 11/28/2011

10:42 : BioDelivery Sciences notches a victory in patent battle - Shares of BioDelivery Sciences rose 6 percent in early trading today after the Raleigh company reported that the U.S. Patent Office rejected a patent infringement claim against the company.
Source : newsobserver-com

BioDelivery Sciences 9/28/2011

17:49 : BioDelivery Sciences International (BDSI) gets hammered post-trading after - BioDelivery Sciences International (BDSI) gets hammered post-trading after it says preliminary findings of its Phase 3 clinical study of BEMA Buprenorphine for the treatment of moderate to severe chronic pain were unsuccessful. ...
Source : seekingalpha-com

BioDelivery Sciences 8/22/2011

13:33 : BioDelivery Sciences drug now being marketed in Canada - BioDelivery Sciences International Inc. said that its drug Onsolis is now being sold in Canada – a development that could generate up to $30 million in sales milestones for the Raleigh-based company. Onsolis is ...
Source : bizjournals-com
10:43 : BioDelivery Sciences drug launching in Canada - BioDelivery Sciences International announced this morning that its oral pain patch for cancer patients, Onsolis, will be launched in Canada this quarter.
Source : newsobserver-com

BioDelivery Sciences 6/1/2011

11:51 : BioDelivery Sciences International Inc. (BDSI) Video Chart for Wednesday, ... - BDSI is on the bottom side of a solid channel that has produced a significant climb each time these levels have been touched.  The indicators are turning and the price per share is drawing support not only from the trend line, but also the 200 day simple ...
Source : ibtimes-com
actualidad BioDelivery Sciences -


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts